Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00708045 · ClinicalTrials.gov registry record · Phase 1
A Multi-modality Imaging Assessment of Chemobrain
A Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT00708045 is a Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 34 participants.
The verdict
NCT00708045, a Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
Patients must have had their breast cancer treated at the Huntsman Cancer Institute to be eligible for this trial. OBJECTIVES: To use quantitative FDG-positron emission tomography (PET), functional MRI (fMRI) and co-registered anatomic MRI imaging to better understand the cognitive disorder known as "chemobrain" which effects up to 16 -50% of individuals receiving long-term adjuvant chemotherapy \[Tannock 2004, Matsuda 2005\]. The study is exploratory to obtain proof of feasibility pilot data to support an eventual submission to the NIH. Neuropsychological Testing A battery of testing will be used to assess the subjective complaints of cognitive impairment in the symptomatic patient cohort. Similarly the same battery of tests will be used to assure that the non-symptomatic patient control group and the age-matched normal controls do not exhibit any cognitive impairment. The following set of clinical tests will be performed to assess the degree of cognitive impairment in all subjects.
Interventions
- DRUG [18F]fluoro-2-deoxy-D-glucose (FDG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2007-05-09 |
| Est. Completion | 2015-02-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00708045
The ClinicalTrials.gov registry entry for NCT00708045 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [18F]fluoro-2-deoxy-D-glucose (FDG) is the first listed.
NCT00708045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00708045 about?
NCT00708045 is a clinical study titled "A Multi-modality Imaging Assessment of Chemobrain". Patients must have had their breast cancer treated at the Huntsman Cancer Institute to be eligible for this trial. OBJECTIVES: To use quantitative FDG-positron emission tomography (PET), functional MRI (fMRI) and co-registered anatomic MRI imaging to better understand the cognitive disorder known ...
What is the current status of trial NCT00708045?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2007-05-09. Estimated completion is 2015-02-05.
What interventions are being tested in trial NCT00708045?
The interventions under investigation include: [18F]fluoro-2-deoxy-D-glucose (FDG) (DRUG).
Who is sponsoring clinical trial NCT00708045?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.